Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO)

34 filings reported holding BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 244,403 shares of 10,213,587 outstanding shares and own 2.39% of the company stock.
Largest 10 shareholders include UBS Group AG (63,876 shares), VANGUARD GROUP INC (50,459 shares), GEODE CAPITAL MANAGEMENT, LLC (26,838 shares), CARRET ASSET MANAGEMENT, LLC (25,000 shares), HRT FINANCIAL LP (20,330 shares), TWO SIGMA SECURITIES, LLC (15,584 shares), STIFEL FINANCIAL CORP (10,513 shares), BlackRock, Inc. (9,937 shares), BANK OF AMERICA CORP /DE/ (8,507 shares), and MORGAN STANLEY (6,208 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.